Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
38.97
-0.10 (-0.26%)
At close: Mar 9, 2026, 4:00 PM EDT
39.55
+0.58 (1.49%)
After-hours: Mar 9, 2026, 7:48 PM EDT
Vera Therapeutics Market Cap
Vera Therapeutics has a market cap or net worth of $2.78 billion as of March 9, 2026. Its market cap has increased by 48.31% in one year.
Market Cap
2.78B
Enterprise Value
2.14B
1-Year Change
48.31%
Ranking
Category
Stock Price
$38.97
Market Cap Chart
Since the IPO on May 14, 2021, Vera Therapeutics's market cap has increased from $225.27M to $2.78B, an increase of 1,134.39%. That is a compound annual growth rate of 68.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 2.79B | -22.45% |
| Dec 31, 2025 | 3.59B | 34.24% |
| Dec 31, 2024 | 2.68B | 291.87% |
| Dec 29, 2023 | 683.38M | 27.69% |
| Dec 30, 2022 | 535.18M | -5.87% |
| Dec 31, 2021 | 568.54M | 152.38% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Edgewise Therapeutics | 2.98B |
| Arcutis Biotherapeutics | 2.98B |
| Catalyst Pharmaceuticals | 2.96B |
| IDEAYA Biosciences | 2.91B |
| Viridian Therapeutics | 2.90B |
| Dianthus Therapeutics | 2.82B |
| Arcus Biosciences | 2.77B |
| Beam Therapeutics | 2.64B |